Edwards Lifesciences (EW) Tops Q4 EPS by 3c; Raises Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Edwards Lifesciences (EW) PT Raised to $150 at BMO Capital
February 2, 2018 8:21 AM ESTBMO Capital raised its price target on Edwards Lifesciences (NYSE: EW) to $150.00 (from $145.00) while maintaining a Outperform rating.
... MoreEdwards Lifesciences (EW) PT Raised to $174 at Canaccord Genuity
February 2, 2018 7:08 AM ESTCanaccord Genuity raised its price target on Edwards Lifesciences (NYSE: EW) to $174.00 (from $140.00) while maintaining a Buy rating. An analysis suggests the stock should trade to at least $174 by year-end, based solely on the fundamentals currently evident in the business, let alone... More
Edwards Lifesciences (EW) PT Raised to $138 at Morgan Stanley
February 2, 2018 6:55 AM ESTMorgan Stanley raised its price target on Edwards Lifesciences (NYSE: EW) to $138.00 (from $130.00) while maintaining a Overweight rating.
... MoreEdwards Lifesciences (EW) PT Raised to $155 at Barclays
February 2, 2018 4:34 AM ESTBarclays raised its price target on Edwards Lifesciences (NYSE: EW) to $155.00 (from $135.00) while maintaining a Overweight rating.
... MoreEdwards Lifesciences (EW) PT Raised to $140 at JMP Securities
February 2, 2018 4:16 AM ESTJMP Securities raised its price target on Edwards Lifesciences (NYSE: EW) to $140.00 (from $135.00) while maintaining a Market Outperform rating.
... More